NYSE · Medical Instruments & Supplies · USD
AptarGroup, Inc. (ATR) Stock Analysis
AptarGroup, Inc. (ATR) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ATR Key Statistics
As of Sep 4, 2026Trading
- Open
- $127.53
- Previous Close
- $128.31
- Day's Range
- 126.53–128.47
- 52-Week Range
- 103.23–146.91
- Volume
- 324.00K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.38
Valuation
- Market Cap
- $8.10B
- P/E Ratio
- 23.17
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 20.17
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 2.68
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.06
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 5.50
Financials (FY)
- Revenue (FY)
- $3.78B+5.42%
- Net Income (FY)
- $392.79M+4.87%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 9.22%
- Shares Outstanding
- 63.58M
- 1-Year Return
- −6.59%
Dividend and dates
- Dividend
- $1.92+1.51%
- Ex-Dividend Date
- July 30, 2026
- Earnings Date
- October 29, 2026
- Avg Volume
- 457.05K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
ATR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +5.66% |
| 2025 | −21.40% |
| 2024 | +28.60% |
| 2023 | +13.89% |
| 2022 | −8.93% |
| 2021 | −9.54% |
| 2020 | +19.87% |
| 2019 | +24.47% |
| 2018 | +10.55% |
| 2017 | +19.32% |
| 2016 (partial year) | −3.15% |
As of September 4, 2026.
ATR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $3.78B | $392.79M | 10.4% |
| 2024 | $3.58B | $374.54M | 10.5% |
| 2023 | $3.49B | $284.49M | 8.2% |
| 2022 | $3.32B | $239.29M | 7.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $3.78B | $1.40B | $510.88M | $392.79M | 10.4% |
| 2024 | $3.58B | $1.36B | $509.50M | $374.54M | 10.5% |
| 2023 | $3.49B | $1.26B | $449.02M | $284.49M | 8.2% |
| 2022 | $3.32B | $1.16B | $385.87M | $239.29M | 7.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
ATR Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.44 | 3 | — |
| 2025 | $1.83 | 4 | +6.4% |
| 2024 | $1.72 | 4 | +8.9% |
| 2023 | $1.58 | 4 | +3.9% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.44 | 3 | — |
| 2025 | $1.83 | 4 | +6.4% |
| 2024 | $1.72 | 4 | +8.9% |
| 2023 | $1.58 | 4 | +3.9% |
| 2022 | $1.52 | 4 | +1.3% |
| 2021 | $1.50 | 4 | +4.2% |
| 2020 | $1.44 | 4 | +1.4% |
| 2019 | $1.42 | 4 | +7.6% |
| 2018 | $1.32 | 4 | +3.1% |
| 2017 | $1.28 | 4 | +300.0% |
| 2016 | $0.32 | 1 | — |
Most recent payment: $0.48 per share, ex-dividend July 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
ATR Valuation vs Medical Instruments & Supplies Median
Median of 55 stocks| Metric | ATR | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/E | 23.17 | 35.61 | 35% below |
| P/S ratio | 2.06 | 3.17 | 35% below |
| Profit margin | 9.22% | 0.85% | 8.4 pts above |
Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
AptarGroup Q2 Earnings Beat Estimates on Pharma & Beverage Growth
YahooWhy AptarGroup (ATR) International Revenue Trends Deserve Your Attention
YahooWells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $155
BenzingaAptarGroup Inc (ATR) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Wins Amid ...
YahooAptarGroup Q2 Earnings Call Highlights
YahooAptarGroup, Inc. (ATR) Q2 2026 Earnings Call Transcript
SeekingAlpha
All 12 articles ↓Show fewer ↑
AptarGroup, Inc. Q2 2026 Earnings Call Summary
YahooAptarGroup, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaAptarGroup (ATR) Tops Q2 Earnings and Revenue Estimates
YahooAptarGroup (NYSE:ATR) Tops Q2 Estimates, Shares Rise After Hours
ChartMillAptarGroup Sees Q3 Adj EPS $1.45-$1.53 vs $1.46 Est
BenzingaAptarGroup Q2 Adj. EPS $1.42 Beats $1.35 Estimate, Sales $1.027B Beat $1.008B Estimate
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$131.38B
BDXBecton, Dickinson and Company
$50.32B
MDLNMedline Inc.
$49.23B
ALCAlcon Inc.
$34.08B
RMDResMed Inc.
$32.94B
WSTWest Pharmaceutical Services, Inc.
$23.93B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B








